Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50,600
Closed -$6.07M 6000
2021
Q4
$6.07M Sell
50,600
-4,100
-7% -$509K 0.01% 2171
2021
Q3
$6.76M Buy
+54,700
New +$7.04M 0.01% 1837
2020
Q3
Sell
-39,700
Closed -$2.58M 4221
2020
Q2
$2.58M Buy
+39,700
New +$2.62M ﹤0.01% 2196

Other funds holding XYL

David Shaw's XYL Position: Q2 2026 in Review

David Shaw reduced its Xylem (XYL) stake by 6.5% in Q2 2026, selling an estimated $4.79M and leaving 600,585 shares worth $71M. The position accounts for 0.03% of the portfolio, ranked #587.

David Shaw first reported a position in XYL in Q2 2013 and has held it in 46 quarters since. The position peaked at $96M in Q3 2025. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • David Shaw held 600,585 shares of Xylem worth $71M as of Q2 2026.
  • David Shaw sold 41,477 Xylem shares in Q2 2026, an estimated $4.79M.
  • Xylem made up 0.03% of David Shaw's portfolio in Q2 2026, its #587 holding.
  • David Shaw first reported a position in Xylem in Q2 2013 and has held it in 46 quarters since.
  • David Shaw's Xylem position peaked at $96M in Q3 2025.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.